The proposed mechanisms of RBP4 effects on cancer cells are dependent on the activation of the signaling receptor and transporter of retinol STRA6 by bound RBP4 and further transduction of the JAK2-STAT3 signaling cascade [18]. Here, JAK2 is linked to cancer.